Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	2.03B
Revenue (ttm)	1.46B
Net Income (ttm)	41.54M
Shares Out	23.66M
EPS (ttm)	1.76
PE Ratio	48.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,770
Average Volume	4,523
Open	85.18
Previous Close	85.63
Day's Range	83.80 - 87.99
52-Week Range	69.00 - 94.99
Beta	0.19
RSI	48.31
Earnings Date	Aug 8, 2025

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 363
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In 2024, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.54 million, a decrease of -43.47%.